Skip to Main content Skip to Navigation
Journal articles

Hypoxia in Lung Cancer Management: A Translational Approach

Abstract : Lung cancer represents the first cause of death by cancer worldwide and remains a challenging public health issue. Hypoxia, as a relevant biomarker, has raised high expectations for clinical practice. Here, we review clinical and pathological features related to hypoxic lung tumours. Secondly, we expound on the main current techniques to evaluate hypoxic status in NSCLC focusing on positive emission tomography. We present existing alternative experimental approaches such as the examination of circulating markers and highlight the interest in non-invasive markers. Finally, we evaluate the relevance of investigating hypoxia in lung cancer management as a companion biomarker at various lung cancer stages. Hypoxia could support the identification of patients with higher risks of NSCLC. Moreover, the presence of hypoxia in treated tumours could help clinicians predict a worse prognosis for patients with resected NSCLC and may help identify patients who would benefit potentially from adjuvant therapies. Globally, the large quantity of translational data incites experimental and clinical studies to implement the characterisation of hypoxia in clinical NSCLC management.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-reims.fr/hal-03325614
Contributor : Valerian Dormoy <>
Submitted on : Wednesday, August 25, 2021 - 10:03:43 AM
Last modification on : Friday, August 27, 2021 - 2:10:41 PM

File

JulienAncel_Cancers_2021.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Julien Ancel, Jeanne-Marie Perotin, Maxime Dewolf, Claire Launois, Pauline Mulette, et al.. Hypoxia in Lung Cancer Management: A Translational Approach. Cancers, MDPI, 2021, 13 (14), pp.3421. ⟨10.3390/cancers13143421⟩. ⟨hal-03325614⟩

Share

Metrics

Record views

8

Files downloads

9